Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)
Tankan Another Sign of 'Better' Japan, Rogers Says
55:31 - Ed Rogers, chief executive of Rogers Investment Advisors in Tokyo, talks about Japan's economy after the Tankan survey showed sentiment among large manufacturers improved for the first time in three quarters. Rogers speaks with Yvonne Man on Bloomberg Television's "First Up." (Source: Bloomberg)
  • Sony's Planned Share Sale Strains Investors' Faith in CEO
  • Tankan Survey Shows Confidence Is Growing in Japan
  • IMF Says Greece Failed to Make $1.7 Billion Payment